Patterns of care of breast cancer patients in Morocco - A study of variations in patient profile, tumour characteristics and standard of care over a decade.


Journal

Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 20 04 2021
revised: 24 06 2021
accepted: 08 07 2021
pubmed: 20 7 2021
medline: 16 10 2021
entrez: 19 7 2021
Statut: ppublish

Résumé

Guided by a national cancer plan (2010-19), Morocco made significant investments in improving breast cancer detection and treatment. A breast cancer pattern-of-care study was conducted to document the socio-demographic profiles of patients and tumour characteristics, measure delays in care, and assess the status of dissemination and impact of state-of-the-art management. The retrospective study conducted among 2120 breast cancer patients registered during 2008-17 at the two premier-most oncology centres (Centre Mohammed VI or CM-VI and Institut National d'Oncologie or INO) also measured temporal trends of the different variables. Median age (49 years) and other socio-demographic characteristics of the patients remained constant over time. A significant improvement in coverage of the state-financed health insurance scheme for indigent populations was observed over time. Median interval between onset of symptoms and first medical consultation was 6 months with a significant reduction over time. Information on staging and molecular profile were available for more than 90% and 80% of the patients respectively. Approximately 55% of the patients presented at stage I/II and proportion of triple-negative cancers was 16%; neither showing any appreciable temporal variation. Treatment information was available for more than 90% of the patients; 69% received surgery with chemotherapy and/or radiation. Treatment was tailored to stage and molecular profiles, though breast conservation therapy was offered to less than one-fifth. When compared using the EUSOMA quality indicators for breast cancer management, INO performed better than CM-VI. This was reflected in nearly 25% difference in 5-year disease-free survival for early-stage cancers between the centres.

Identifiants

pubmed: 34280610
pii: S0960-9776(21)00418-5
doi: 10.1016/j.breast.2021.07.009
pmc: PMC8319441
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-202

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Hind Mrabti (H)

Institut National d'oncologie, CHU-Rabat, Rabat, Morocco.

Catherine Sauvaget (C)

Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.

Abdellatif Benider (A)

Registre des Cancers de la Région du Grand Casablanca, Casablanca, Morocco.

Karima Bendahhou (K)

Registre des Cancers de la Région du Grand Casablanca, Casablanca, Morocco.

Farida Selmouni (F)

Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.

Richard Muwonge (R)

Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.

Leila Alaoui (L)

National Cancer Institute, Fes, Morocco.

Eric Lucas (E)

Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.

Youssef Chami (Y)

Lalla Salma Foundation, Prevention and Treatment of Cancers, Rabat, Morocco.

Patricia Villain (P)

Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.

Loubna Abousselham (L)

Cancer Unit, Epidemiology and Disease Control Department, Ministry of Health, Rabat, Morocco.

Andre L Carvalho (AL)

Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.

Maria Bennani (M)

Lalla Salma Foundation, Prevention and Treatment of Cancers, Rabat, Morocco.

Hassan Errihani (H)

Institut National d'oncologie, CHU-Rabat, Rabat, Morocco.

Rengaswamy Sankaranarayanan (R)

RTI International India, New Delhi, India.

Rachid Bekkali (R)

Lalla Salma Foundation, Prevention and Treatment of Cancers, Rabat, Morocco.

Partha Basu (P)

Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France. Electronic address: basup@iarc.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH